[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-350788-105":59,"doc-detail-350788-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","cancer-associated-fibroblasts-as-architects-of-acquired-immune-privileged-like-niches-in-gastrointestinal-cancers-lessons-from-ocular-immune-privilege-and-barrier-biology","Cancer-associated fibroblasts as architects of acquired immune-privileged-like niches in gastrointestinal cancers - lessons from ocular immune privilege and barrier biology","","Gastrointestinal cancers often show immune exclusion and therapeutic resistance, which are frequently discussed separately. The article argues that cancer-associated fibroblasts (CAFs) act as stromal architects of immune-excluded microenvironments and that therapy can educate heterogeneous CAF states through injury, inflammation, hypoxia, and repair signals. These therapy-educated CAFs are proposed to form acquired immune-privileged-like niches via extracellular matrix remodeling, immunosuppressive secretomes, vascular-barrier changes, and spatial exclusion of cytotoxic immune cells.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cancer-associated-fibroblasts-as-architects-of-acquired-immune-privileged-like-niches-in-gastrointestinal-cancers-lessons-from-ocular-immune-privilege-and-barrier-biology/350788/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cancer-associated-fibroblasts-as-architects-of-acquired-immune-privileged-like-niches-in-gastrointestinal-cancers-lessons-from-ocular-immune-privilege-and-barrier-biology/350788.png","ImageObject",300,407,{"name":92,"@type":93},"acoobca","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-12","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What tumor features does the article focus on in gastrointestinal cancers?","Question",{"text":112,"@type":113},"It focuses on immune exclusion and therapeutic resistance, emphasizing how these features relate to how immune cells are spatially organized within the tumor microenvironment.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do cancer-associated fibroblasts (CAFs) contribute to immune exclusion?",{"text":117,"@type":113},"The article describes CAFs as dynamic, heterogeneous, and therapy-responsive stromal populations that remodel extracellular matrix, shape cytokine gradients, influence vascular behavior, and position immune cells in ways that restrict cytotoxic lymphocyte access.",{"name":119,"@type":110,"acceptedAnswer":120},"What does “acquired immune-privileged-like niches” mean in this framework?",{"text":121,"@type":113},"It refers to microenvironment states induced by treatment that resemble immune-privileged organization conceptually, integrating matrix remodeling, immunosuppressive secretomes, vascular-barrier remodeling, and spatial exclusion of CD8+ T cells and NK cells.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},350788,1790474846,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":46,"preview_page_count":19,"preview_urls":144},3985747870733,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","TYPE Perspective  \nPUBLISHED 25 August 2026  \nDOI 10.3389/fimmu.2026.1946857  \nOPEN ACCESS  \nEDITED BY  \nQiong Lu,  \nCentral South University, China  \nREVIEWED BY  \nPaola Chiodelli,  \nUniversity of Brescia, Italy  \n*CORRESPONDENCE  \nDao Xin  \n[xindao5230@zzu.edu.cn](xindao5230@zzu.edu.cn)[ ](xindao5230@zzu.edu.cn)Bingtong Yue  \n[yuebingtong@stu.zzu.edu.cn](yuebingtong@stu.zzu.edu.cn)[ ](yuebingtong@stu.zzu.edu.cn)Feng Wang  \n[zzuwangfeng@zzu.edu.cn](zzuwangfeng@zzu.edu.cn)[ ](zzuwangfeng@zzu.edu.cn)†These authors have contributed equally to this work and share ﬁrst authorship  \n‡These authors have contributed equally to this work and share last authorship  \nRECEIVED 23 July 2026  \nREVISED 03 August 2026  \nACCEPTED 04 August 2026  \nPUBLISHED 25 August 2026  \nCITATION  \nWang Y, Wang Z, Zhou F, Qiao Y, Luo Z, Wang F, Yue B and Xin D (2026) Cancerassociated ﬁbroblasts as architects of acquired immune-privileged-like niches in gastrointestinal cancers:  \nlessons from ocular immune privilege and barrier biology.  \nFront. Immunol. 17:1946857 .  \ndoi: 10.3389/fimmu.2026.1946857  \nCOPYRIGHT  \n© 2026 Wang, Wang, Zhou, Qiao, Luo, Wang, Yue and Xin. This is an openaccess article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nCancer-associated ﬁbroblasts as architects of acquired immuneprivileged-like niches in gastrointestinal cancers: lessons from ocular immune privilege and barrier biology  \nYingjian Wang1†, Zhe Wang2†, Fangdi Zhou 3†, Yu Qiao 4,  \nZhanyang Luo 5, Feng Wang 2*‡, Bingtong Yue 6*‡ and Dao Xin 2*‡  \n1 Department of Urology, The First Afﬁliated Hospital of Zhengzhou University, Zhengzhou,  \nHenan, China, 2 Department of Oncology, The First Afﬁliated Hospital of Zhengzhou University, Zhengzhou, China, 3 Department of Ophthalmology, The First Afﬁliated Hospital of Zhengzhou University, Zhengzhou, Henan, China, 4 Department of Orthopaedics and Sports Orthopaedics, TUM University Hospital, Technical University of Munich, Munich, Germany, 5 Department of Pharmacy, Shanghai Pudong Hospital, Fudan University Pudong Medical Center, Shanghai, China, 6 Department of Colorectal Surgery and Oncology, Key Laboratory of Cancer Prevention and Intervention, Ministry of Education, The Second Afﬁliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China  \nGastrointestinal cancers frequently develop immune exclusion and therapeutic resistance, yet these phenotypes are often described separately. Cancer-associated ﬁbroblasts (CAFs) are key stromal architects of immune-excluded tumor microenvironments, and their heterogeneous states can evolve under chemotherapy, radiotherapy, immunotherapy, targeted therapy, and anti-angiogenic pressure. We propose that treatment-induced injury, inﬂammation, hypoxia, and repair signals reshape CAFs. These therapy-educated CAFs can construct acquired immune-privileged-like niches by integrating extracellular matrix remodeling, immunosuppressive secretomes, vascular-barrier remodeling, and spatial exclusion of cytotoxic immune cells. Ocular barrier biology offers a conceptual, not anatomical, analog for this spatial organization. In gastrointestinal tumors, these principles may be pathologically co-opted by myCAF-, iCAF-, and apCAF-like programs to restrict CD8+ T-cell and NK-cell access, recruit suppressive myeloid and regulatory populations, and impair drug delivery. This framework may guide spatial multiomics, digital pathology, radiomics, CAFderived biomarkers, and spatially guided CAF reprogramming strategies. It also provides falsiﬁable questions for paired pre-and post-treatment sampling across gastrointestinal can","cbCaitFXPZczh3Bb","https://ap.wps.com/l/cbCaitFXPZczh3Bb","pdf",1490775,"English","# Introduction\n## Immune exclusion as a key clinical phenotype\n## CAFs as dynamic architects of tumor microenvironments\n# Proposed framework\n## Therapy-educated CAF-driven acquired immune-privileged-like niches\n## Implications for spatial profiling and biomarker discovery","[{\"question\":\"What tumor features does the article focus on in gastrointestinal cancers?\",\"answer\":\"It focuses on immune exclusion and therapeutic resistance, emphasizing how these features relate to how immune cells are spatially organized within the tumor microenvironment.\"},{\"question\":\"How do cancer-associated fibroblasts (CAFs) contribute to immune exclusion?\",\"answer\":\"The article describes CAFs as dynamic, heterogeneous, and therapy-responsive stromal populations that remodel extracellular matrix, shape cytokine gradients, influence vascular behavior, and position immune cells in ways that restrict cytotoxic lymphocyte access.\"},{\"question\":\"What does “acquired immune-privileged-like niches” mean in this framework?\",\"answer\":\"It refers to microenvironment states induced by treatment that resemble immune-privileged organization conceptually, integrating matrix remodeling, immunosuppressive secretomes, vascular-barrier remodeling, and spatial exclusion of CD8+ T cells and NK cells.\"}]","Cancer-associated fibroblasts as architects of acquired immune-privileged-like niches in gastrointestinal cancers - lessons from ocular immune privilege and barrier biology | PDF",1790091097,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2210933d9703d443c3cddbd3d5d2b062.webp",983,1389,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3b59c8ca20d1fcd38877e9a406b4f099.webp",982,1388,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9bbbaae743e8781ba0f7d8be68db2ca0.webp",981,1386,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b9f22d3c23904649336565254ffbe4dd.webp",980,1385]